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ABSTRACT 
Growing evidence from many in vitro studies suggest that plants produce 
secondary metabolites which may have potential physiological properties. The 
northern highbush blueberry (Vaccinium corymbosum L.) plant is commercially 
cultivated for its valuable dark-blue fruit, which has been extensively researched and 
has been shown to contain phenolic compounds recognized to have positive health 
benefits. Thus, an evaluation of other parts of the plant, that as of yet have not been 
investigated, could be worthwhile. There may be undiscovered bioactive compounds 
within the roots of this plant that may contribute to the improvement of human health. 
This rationale supports further research and investigation into the roots of the plant.  
A preliminary study showed that the crude extract of the blueberry roots showed 
antioxidant activity. Using various chromatographic methods and spectroscopic 
techniques, the blueberry root compounds were isolated, fractionated and analyzed. 
Six compounds were identified by 1H and 13C NMR and mass spectrometry data. 
Three lignans, which were never previously reported in the blueberry plant, were 
identified as nudiposide, lyoniside, and ssioriside; one phenolic acid; sinapic acid 
glucoside, and two catechins; epigallocatechin (EGC) and dulcisflavan. The isolated 
compounds were evaluated for inhibitory effect on α-glucosidase and tyrosinase. Of 
the six compounds evaluated, ssioriside was a moderate inhibitor of α-glucosidase 
(IC50 = 650µM) and epigallocatechin showed weak tyrosinase enzyme inhibition 
activity (IC50 = 2001µM).
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PREFACE 
This thesis has been written in manuscript format. It is broken into two 
sections. Part I is a literature review, covering previous work on Vaccinium 
corymbosum, the history behind natural product chemistry and the scientific methods 
behind extraction and isolation of secondary plant metabolites. Part II contains the 
research section, covering methods used to determine phenolic compounds using 
scientific instrumentation.  
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PART I. INTRODUCTION 
1. Review of Previous work on Northern Highbush Blueberry  
The Northern highbush blueberry (Vaccinium corymbosum L.) is a deciduous 
plant in the family Ericaceae, which is often found in dense thickets (Rowland et al., 
2012). The alternate names of this plant are southeastern highbush blueberry, 
Maryland highbush blueberry, black highbush blueberry, American blueberry, New 
Jersey blueberry, swamp blueberry, and whortleberry depending on the location of 
where it is grown (Rowland, Alkharouf, Darwish, Ogden, & Main, 2012).  
Northern highbush blueberry is native to eastern North America, growing from 
Nova Scotia and Ontario south to Alabama and west to Wisconsin. The name 
“highbush” refers to the relatively tall stature of the plant, which can grow upwards of 
6 to 12 feet tall (Rowland, Alkharouf, Darwish, Ogden, & Main, 2012). The stems are 
a reddish color in the winter and a yellow-green color from the spring to fall. The 
leaves are 1 to 3 inches long and elliptical in shape. Generally blooming around 
February to June, the small white flowers of the highbush plant are bell-shaped with 5 
petals, and arranged in clusters of about 8 to 10 flowers per cluster. Fruiting occurs 
approximately two months after flowering. When mature, the round, small fruit 
contains many seeds and has a dark blue color which attracts the attention of 
numerous birds and mammals, providing them an important summer and early fall 
food. The consumption of the fruit by the animals helps aid in the dispersion of the 
undigested seeds elsewhere (Rowland, Alkharouf, Darwish, Ogden, & Main, 2012).  
The highbush blueberries are commercially cultivated for their dark blue fruits 
and are known to be beneficial to human health (Torri, Lemos, Caliari, Kassuya, 
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Bastos, & Andrade, 2007). The use of blueberries for medicinal purposes has a long 
history.  Early North American settlers consumed blueberries as a tea or syrup to help 
with cough and diarrhea (Kalt & Dufour, 1997). Today, blueberries are still being 
consumed, and are known to contain a wide range of phytochemicals that are 
beneficial to human health.  The multitude of health benefits include; antioxidant, anti-
cancer, anti-bacterial, anti-neurodegenerative and anti-viral (Alejandro, Eicholz, Rohn, 
Kroh, & Huyskens-Keil, 2008; Torri, Lemos, Caliari, Kassuya, Bastos, & Andrade, 
2007; Wan, Yuan, Cirello, & Seeram, 2012). It is known that blueberries have one of 
the highest levels of antioxidant capacity among many fruits and vegetables (Zeng & 
Wang, 2003).  
Generic and environmental conditions affect the distribution and composition 
of anthocyanins in blueberries worldwide.  (Ayaz, Hayirlioglu-Ayaz, Gruz, Noyak, & 
M., 2005). Ten known anthocyanins were identified in the North American Highbush 
blueberry, which include; 3-monoarabinosides, 3-monogalacatosides and 3-
monoglucosides of cyanidin, delphinidin, malvidin, peonidin and petunidin (Castrejon, 
Rohn, Kroh, & Huyskens-Keil, 2008; Meadows, Smith, Greenwood, Haight, Perez-
Pons, Querol, et al., 1996). In Slovenia, Moze et al., fifteen anthocyanins were 
identified in planted Slovenian blueberries. This may be due to many factors such as 
climatic differences or the ripeness of the fruit when cultivated  (Moze, Polak, 
Gasperlin, Koron, Vanzo, Ulrih, et al., 2011).  
There are recent investigations of the non-edible plant parts due to numerous 
reports throughout the literature pertaining to the health benefits of the blueberry fruit. 
According to a study from Takeshita et al., other parts of the plant reveal potential 
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therapeutic values. The group confirmed that a crude extract from the leaves of the 
rabbit-eye blueberry (V. ahsei) inhibited Hepatitis C virus (HCV) RNA expression, in 
vitro (Takeshita, Yo-ichi, Akamatsu, Ohmori, U., Tsubouchi, et al., 2009). This data 
suggests that the compounds within the leaves extracts could be used to inhibit the 
viral replication of the HCV infection (Takeshita, et al., 2009). Another non-edible 
part of the blueberry plant that has been recently investigated is the flowers. Wan et al. 
showed that compounds isolated from the flowers were potent inhibitors of α-
glucosidase enzymes. It was noted that the phenolic sub-classes were more potent than 
the positive control, acarbose (Wan et al., 2012). The roots of the blueberry plant 
would make a great candidate to investigate the phytochemicals since there is 
numerous health benefits linked with this plant and there are no known phytochemical 
investigations of the roots 
2. Natural Product Chemistry: 
  For thousands of years, natural products from plants, bacteria, sponges and 
fungi have been used to treat and cure illnesses (Butler, 2004). The most historically 
practiced medicinal chemistry is that of traditional Chinese medicine (TCM) and 
Ayurveda, the traditional Indian system of medicine. According to Butler, drugs 
derived from natural products have spiked global interest from pharmaceutical and 
biotech companies, which seek to produce drugs derived from natural sources. It is 
currently known that 15 natural product derived drugs are on the market and 15 are in 
Phase III clinical trials (Butler, 2004; Newman & Cragg, 2012; Newman, Cragg, & 
Snader, 1999). An example of a drug from natural product origin is, Taxol. Extracted 
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from the Pacific Yew tree, Taxol is a powerful anticarcinogenic clinical drug used in 
cancer chemotherapy (Cragg & Newman, 2005). 
Natural Product Chemistry is a field of research that deals with the isolation 
and identification of these active compounds found in nature (Butler, 2004). There are 
two main techniques used to isolate pure compounds from natural sources. These 
techniques include: extraction of the crude extract and purification of the sample using 
chromatography. The most common methods used to identify the isolated pure, 
unknown compounds are: mass spectroscopy, nuclear magnetic resonance 
spectroscopy (NMR) and x-ray crystallography (Newman & Cragg, 2012).  
 Plant organisms contain an enormous variety of chemical compounds. These 
compounds are known as primary and secondary metabolites. Primary metabolites are 
required by the organism to survive. These essential biochemical compounds are: fats, 
proteins, carbohydrates and vitamins. Secondary metabolites are key components in 
aiding an organism’s defense against herbivores and other interspecies. The health-
promoting importance of these compounds has been recognized by researchers (Cragg 
& Newman, 2005). Therefore, there is an interest in the isolation and characterization 
of active phenolic compound due to their antioxidant, anti-inflammatory, 
anticarcinogenic and antimicrobial properties, to list a few (Eliane, Lemos, Caliari, 
Kassuya, Bastos, & Andrade, 2007; Wan, Yuan, Cirello, & Seeram, 2012). It is 
estimated that only 1/3 of the plants in the world have been investigated for their 
chemical constituents, leaving numerous possibilities for discovery of  potential drug 
candidates (Butler, 2004; Cragg & Newman, 2005). 
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3. Extraction and Isolation: 
 Natural product extracts contain complex undetermined chemical entities that 
require proper characterization. These compounds are isolated from various parts of 
plants such as roots, barks, leaves, flowers, fruits and seeds (Newman, Cragg, & 
Snader, 1999). In this work, the crushed plant roots were partitioned using two 
different polarity solvents, butanol (more polar) and ethyl acetate (less polar). A polar 
solvent system is used to eliminate components of the plant such as waxes, fatty acids, 
sterols, chlorophylls and terpenes. The fractions are then further isolated through 
chromatography using different stationary phases. There are several types of resins 
that can be used to further purify a fraction. The choice of method depends on the 
stability of the analyte and the physical state of the sample. The most commonly used 
technique for separation of compounds involves developed HPLC methods. Common 
resins used to separate compounds are: Sephadex TM LH-20, C-18, XAD-16 and MCI. 
Sephadex LH-20 is a cross-linked, dextran-based resin. It separates compounds 
based on molecular size and polarity. The bead cross-linked dextran contains a 
hydrophobic characteristic. Depending on the solvent used, the LH-20 resin will 
expand to different sizes, limiting what is eluted. 
 C-18 columns are packed with silica particles that are bonded to 18 carbon 
chain units in length, making this reverse phase column hydrophobic. When a sample 
is loaded onto the column, the polar compounds will elute first followed by the non-
polar material which will elute later due to increased partitioning into the lipophilic 
stationary phase (like-dissolves-like rule). Generally, a gradient solvent system 
(organic: aqueous) with increasing organic content would be used to elute the 
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compounds. Common, organic solvents that are used to elute the compounds are 
methanol and acetonitrile.  
XAD-16 resin is used to absorb hydrophobic molecules from polar solvents. Its 
characteristic pore size allows for the absorption of organic substances of relatively 
low to medium molecular weight. A gradient system of decreasing polarity is used. 
MCI chromatography is a reverse-phase column that separates the compounds 
into structurally similar groups. A gradient system of decreasing polarity is used. 
Once a compound is isolated and in its purest form it’s structure can then be 
elucidated by NMR (Kwan & Huang, 2008). The mass of the pure compound can also 
be determined by using a Mass Spectrometer. With the help of these instruments, an 
analyst is frequently able to determine the chemical structure of the isolated compound 
(Stalikas, 2007). 
3.1. Flavonoids: 
A wide variety of flavonoids are introduced into the human diet through the 
consumption of fruits and vegetables (Lila, 2004). They make up a broad group of 
natural product compounds with useful biological properties. The common carbon-
skeleton for these large groups consist of C6-C3-C6 structure characterization. 
Anthocyanins are common flavonoids responsible for the dark pigments found in 
fruits and vegetables (Takanori, 2012). They play an important role in plant life as a 
protecting agent against infection (bacterial, viral and fungal), UVB protection, 
pollination and plant and animal interaction (Su, 2012). They are also well known for 
efficiently scavenging and neutralizing free radicals which can cause damage to cells 
within the body (Lila, 2004). Flavonoids have been reported to have important 
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biological activity such as anti-spasmodic, hepatoprotective, anti-inflammatory, and 
antiviral activity in animal models (Van Acker, De Groot, Van Den Berg, Tromp, 
Kelder, Van Der Vijgh, et al., 1996).  
 
Figure 1: Basic skeletal structure of a Flavonoid 
 
3.2. Hydroxycinnamic acids: 
 Hydroxycinnamic acids are non-flavonoid phenolics responsible for the 
integrity of the plant’s cell wall structure as well as a defense mechanism against 
pathogens. These compounds are known to have UV protective and anticancer 
properties. (Faulds & Williamson, 1999). 
 
Figure 2: Basic skeletal structure of a Hydroxycinnamic acid 
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 3.3. Lignans: 
 Lignans are a class of naturally occurring secondary metabolites within the 
plant and animal kingdoms. Lignans are produced through the oxidative dimerization 
of two linked phenylpropanoid units (C3-C6). They are frequently studied in the 
scientific community due to their ability to mimic the hormone estrogen. Compounds 
able to do this are known as phytoestrogens (Saleem, Kim, Shaiq, & Lee, 2005). 
Lignans are believed to be linked with breast cancer prevention. When there is an 
abundance of estrogen in the body, lignans may reduce the levels by displacing it from 
the cells. By decreasing estrogen levels, breast cancer cells are unable to grow and 
divide. Even though the biological activity of lignans is still unclear, they are known 
to have potent properties for antimicrobial, antifungal, antiviral, antioxidant, 
insecticidal and anti-feeding. Some speculate that lignans may participate in plant 
growth and defense mechanisms. Lignans have been isolated from various parts of the 
plant, including wooded parts, leaves, flowers, fruits and seeds (Smeds, Eklund, 
Sjohnolm, Willfor, Nishida, Deyama, et al., 2007). 
 
Figure 3: Basic skeletal structure of a Lignan  
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4. Family: Ericaceae 
 The Ericaceae family consists of 4000 species from 126 genera. This family is 
also commonly known as the heath family (Routray & Orsat, 2011). They are 
distributed worldwide, especially in the cooler areas of the northern hemisphere, but 
absent in continental Antarctica, central Australia and Greenland.  They strive in 
acidic soils and the roots are usually closely associated with fungi for nutrients 
(Rowland, Alkharouf, Darwish, Ogden, & Main, 2012).  Examples of some of the 
commercially well-known Ericaceae plants are; cranberries, blueberries, huckleberry 
and rhododendron. This family consists of a diverse group of plants. It contains plants 
that are shrubs, herbs, and trees and the petals are fused funnel shaped or widely bowl-
shaped (Rowland, Alkharouf, Darwish, Ogden, & Main, 2012). 
5. Genus: Vaccinium  
 Vaccinium is a morphologically diverse genus of shrubs or lianas.  The 
common commercially grown Vaccinium species are; huckleberry, cranberry, 
whortleberry, lingonberries and blueberry (Routray & Orsat, 2011). This group of 
approximately 450 species is especially recognized for its wide range of therapeutic 
compounds (Su, 2012).  Of these compounds, the production of flavonoids and 
anthocyanins are well documented from this genus (Routray & Orsat, 2011). The 
extracts and isolates from the leaves and fruits contain antioxidative, antinociceptive, 
anti-inflammatory, antitumor, antiviral, vasoprotective, and antiviral properties (Torri, 
Lemos, Caliari, Kassuya, Bastos, & Andrade, 2007). The phenolic compounds from 
the Vaccinium berry and leaves may have commercial value in the pharmaceutical and 
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cosmetic industry due to their potential health benefits. (Su, 2012; Torri, Lemos, 
Caliari, Kassuya, Bastos, & Andrade, 2007).  
5.1. Vaccinium corymbosum (Northern Highbush Blueberry) 
Vaccinium corymbosum, commonly known as the highbush blueberry is one of 
the most commercially cultivated fruit crops in North America (Routray & Orsat, 
2011).  It is known for its dark blue fruits that are beneficial to human health. 
Investigations of various species of Vaccinium, such as cranberry, bilberry, and 
huckleberry, have shown the fruits to contain a wide range of phytochemicals that are 
antioxidant, anti-cancer, anti-bacterial anti-viral and anti-aging (Adams, Phung, Yee, 
Seeram, Li, & Chen, 2010; Alejandro, Eicholz, Rohn, Kroh, & Huyskens-Keil, 2008; 
Wilson, Shukitt-Hale, Kalt, Ingram, Joseph, & Wolkow, 2006). It is known that 
blueberries have one of the highest levels of antioxidant capacity among most fruits 
and vegetables (Zeng & Wang, 2003).  
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Abstract 
Growing evidence from many in vitro studies suggest that secondary metabolites 
produced by plants may have potential physiological properties. The Northern 
Highbush blueberry (Vaccinium corymbosum L.) plant is commercially cultivated for 
its valuable dark-blue, sweet fruit. This small round fruit has been extensively 
researched and shown to contain phenolic compounds that are praised for having 
positive health benefits. Thus, it would be worthwhile to evaluate other parts of the 
plant that as of yet have not been investigated. There may be undiscovered bioactive 
compounds within the roots. Blueberry root compounds were extracted and their 
phytochemical constituents were isolated using chromatographic techniques and 
identified by spectroscopic techniques. Six phenolic compounds were identified by 1H 
and 13C NMR and mass spectrometry data. Three lignans, which were not previously 
reported in the blueberry plant, were identified as; lyoniside, nudiposide and ssioriside 
(1-3); one phenolic acid, sinapic acid glycoside and two catechins, dulcisflavan and 
epigallocatechin were identified (4-6). The isolated compounds were evaluated for 
inhibitory effect on of tyrosinase and α-glucosidase . Overall, of the six compounds 
elucidated, ssioriside (3) showed moderate inhibition of α-glucosidase enzyme and 
epigallocatechin (6) was a weak inhibitor of tyrosinase enzyme.  
Keywords: Vaccinium corymbosum; Highbush blueberry flowers; Phenolics; 
Antioxidant activity; α-glucosidase inhibition; Tyrosinase inhibition 
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1. Introduction: 
 Northern Highbush blueberries are commercially grown in northern states of 
North America (Wan, Yuan, Cirello, & Seeram, 2012). They are bred for consumption 
as fresh fruit along with being processed into jams, juice, syrups, teas and sweets. The 
highbush blueberry differs from that of the lowbush blueberry in the way it is grown. 
Highbush blueberries are grown on plantations while lowbush blueberries are wildly 
grown. They are also phenotypically different in height, leaf color and fruit size 
(Routray & Orsat, 2011). Both are noted for their high antioxidant capacities which 
have been linked to the anthocyanin pigment content of the fruit (Su, 2012). The major 
compounds found in blueberries are flavonoids and phenolic acids. It is also known 
that blueberries contain condensed tannins known as proanthocyanidins (Torri, Lemos, 
Caliari, Kassuya, Bastos, & Andrade, 2007). These complex compounds are known 
for their activity  in inhibiting the beginning stages of chemically-induced 
carcinogenesis. A known cancer preventative compound from the fruit of the wild 
blueberry is quercetin, which is also found in wine (Bilyk & Sapers, 1986). 
Blueberries are one of the most abundant sources of phenolic compounds. The major 
glycosides found in Northern Highbush blueberry are derivatives of malvidin and 
delphinidin (Kader, Rovel, Girardin, & Metche, 1995). Stilbenes have been reported to 
be present in blueberries (Rimando, Kalt, Magee, Dewey, & Ballington, 2004). They 
are reported to exhibit significant effects against cell proliferation,  inflammation, 
lowering cholesterol in animal models and to reverse the effects of aging in hamsters 
(Rimando & Cody, 2005; Rimando, Nagmani, Feller, & Wallace, 2005). Yi et al. 
reported that the phenolic compounds in rabbiteye blueberry (V. ashei) can inhibit 
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cancerous cell proliferation and induce cancer cell apoptosis (Yi, Fischer, Krewer, & 
Akoh, 2005). 
Blueberries are not only known for their antioxidant ability; a preliminary 
study has shown that blueberry supplementation may improve memory in older adults 
(Krikorian, Eliassen, Nash, & Shidler, 2010; Rimando & Nagatomi, 2005). According 
to Krikorian et al., adults with early stages of memory loss were analyzed for 12 
weeks. During this time, they were given either blueberry juice or a placebo and were 
then tested for memory performance. Those given the blueberry juice tested had 
higher scores, suggesting that the juice may have neurocognitive benefits (Krikorian, 
Eliassen, Nash, & Shidler, 2010).  
Our group recently isolated bioactive compounds from the flowers of the 
blueberry plant (Wan, Yuan, Cirello, & Seeram, 2012). The flowers were investigated 
and evaluated for their antioxidant and α-glucosidase inhibitory activities. Out of the 
21 phenolics isolated the phenylpropanoid-substituted catechins and the flavonol 
glycosides showed superior antioxidant activity compared to the positive control, 
vitamin C and butylated hydroxytoluene. The phenolic sub-classes were more potent 
α-glucosidase inhibitors than the clinical drug, acarbose.  This provided our group 
with stronger evidence that the non-consumed parts of food plants may be a source of 
bioactive compounds (Wan, Yuan, Cirello, & Seeram, 2012). 
The objectives of this project were to isolate, elucidate, and biologically 
evaluate (for antioxidant activity and inhibition of tyrosinase and α-glucosidase 
enzymes) phytochemicals in the roots of the highbush blueberry plants.  This is the 
first phytochemical and biological study of roots of the highbush blueberry species.  
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2. Materials and Methods 
2.1. General Experimental Procedures 
 Optical rotations were measured on an Auto Pol III automatic polarimeter 
(Rudolph Research, Flanders, NJ, USA). Compounds 1-3 were analyzed on a Bruker 
400 MHz NMR whereas compound 6 was analyzed on a Bruker 300 MHz NMR and 
compounds 4 & 5 were analyzed on a Varian 500 MHz NMR instrument with TMS as 
an internal standard. The chemical shifts (δ) are expressed in parts per million and 
coupling constants (J), in hertz. Deuterated methanol (methanol-d4) was used as a 
solvent for all NMR experiments. All mass spectral data was obtained on a Sciex Q-
Star Elite (Applied Biosystems MDS) equipped with a Turbo-Ionspray source. The 
UV spectra were measured on a SHIMADZU UV-2550 UV-visible 
spectrophotometer. High performance liquid chromatography (HPLC) were performed 
on a Hitachi Elite LaChrom system consisting of an L2130 pump, an L-2200 
autosampler and an L-2455 diode array detector using a Waters Sunfire C18 column 
(250 x 10 mm 5 µM), were operated by EZChrom Elite software. All solvents were 
ACS or HPLC grade and were purchased from Wilkem Scientific (Pawtucket, RI). α-
Glucosidase (yeast, EC 3.2.1.20) powder, mushroom  tyrosinase, 4-nitrophenyl-α-D-
glucopyranoside, 1,1-diphenyl-2-picrylhydrazyl (DPPH), ascorbic acid (vitamin C) 
and butylated hydroxytoluene (BHT), were all purchased from Sigma-Aldrich (St. 
Louis MO).  Unless otherwise specified, all other chemicals were purchased from 
Sigma-Aldrich (St. Louis, MO). 
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2.2 Extraction of Blueberry Roots 
The whole root material of the highbush blueberry species (Vaccinium 
corymbosum var. ‘Jersey’) were collected locally from Morgan farms (North 
Kingstown, RI, USA) in December 2009.  The roots were dried in an oven for 48 
hours and then grounded using a Draper® Garden Shredder.  Voucher specimens 
(16JPM51-VCBR12809R) are deposited in the Heber-Youngken Garden at the 
College of Pharmacy, University of Rhode Island (Kingstown, RI, USA).  The ground 
roots (400 g, fresh weight) were submerged in methanol (2000 mL) and mixed for 72 
hours to extract all phenolic compounds.  The roots were then filtered and the solvent 
was dried to obtain a methanol extract (80g).  
The crude extract was re-dissolved in water (1000 mL). The extract was 
partitioned using two polar solvents. The solvents used were butanol vs. water and 
ethyl acetate vs. water as shown in Figure 1. All the masses of extracts and fractions 
are presented in more detail in the Results and Discussion section.  
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Figure 4. Extraction and isolation scheme of compounds 1–6 from Northern 
Highbush blueberry roots. 
 
2.3 Isolation of Compounds  
Figure 4 shows a detailed flow chart of the isolation of compounds from the highbush 
blueberry roots. Briefly, the butanol extract (50.9 g) was loaded onto an XAD-16 resin 
column (45 x 3 cm), and eluted with a gradient solvent system of methanol in aqueous 
water (0.1% trifluoroacetic acid, TFA) to obtain five major fractions A-1 through A-5 
which were combined based on analytical HPLC analyses. Fraction A-5 (0.79g) was 
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further purified over an LH-20 column using a methanol/water gradient system to 
obtain five fractions, B1 through B5. Fraction B1 (400 mg) was then absorbed onto a 
smaller LH-20 column using an isocratic solvent system of methanol to obtain two 
sub-fractions. Similar fractions were combined by analyzing their chromatogram on an 
HPLC. Of those fractions, one fraction (15.45 mg) containing three peaks was 
individually purified by semi-preparative HPLC using a Waters Sunfire Prep C18 
column (10 x 250 mm, i.d., 5 µm; flow 2mL/min.) with a gradient elution system of 
methanol water. The program used was: 0–40 minutes 30% methanol; 40–45 minutes 
60% methanol; 45–50 minutes 30% methanol. The peaks were collected over several 
runs according to the retention
 
time (RT) and absorbance wavelength. The compounds 
isolated, according to NMR and Mass spectra data were: lyoniside (1) (2.6 mg; dark 
yellow powder), nudiposide (2) (2.6 mg; dark yellow powder), and ssioriside (3) (1.9 
mg; dark yellow powder).  
 Fraction A2 (0.43 g) was further purified and loaded onto a small LH-20 
column. Through repeated analytical HPLC, similar fractions were combined. Of the 
similar compounds, one fraction was loaded onto a semi-preparative HPLC C18 
column at 50 µL of sample per injection. According to NMR  is sinapic acid glucoside 
(4) (2.5 mg; yellow powder). The ethyl acetate fraction (13.3 g) was loaded onto an 
MCI resin column (45 x 3 cm), and eluted with a gradient solvent system of methanol 
and water (0.1% trifluoroacetic acid, TFA) to obtain six major fractions C-1 through 
C-6. Fraction C-1 (4.89g) was further purified over an LH-20 column (45x3cm) using 
a methanol/water gradient system to obtain four sub-fractions D1 through D4. Fraction 
D3 (1.1g) was then absorbed onto a smaller LH-20 column using an isocratic solvent 
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system of methanol to obtain sub-fractions. Through repeated analytical HPLC 
analysis, similar fractions were combined. Of those fractions, D3b (310.7mg) which 
contained four peaks, was further purified using preparative HPLC and a Waters 
Sunfire Prep C18 column (10 x 250 mm, i.d., 5 µm; flow 2mL/min.) with an isocratic 
system of 25% methanol in water for 35 minutes. The peaks were collected over 
several runs according to the RT
 
and absorbance wavelength. The compound isolated 
according to NMR and Mass spectral data was dulcisflavan (5) (3.2 mg; light brown 
powder).  
The similarly profiled fractions from Fraction D-3 were combined to give D3d. 
This fraction was loaded onto a semi-preparative HPLC C18 column at 50 µL of 
sample per injection with an isocratic system of 80% aqueous and 20% organic for 55 
minutes. The compound isolated was epigallocatechin (EGC) (6) (3.6 mg; light brown 
powder).  
2.4 Identification of Compounds  
 All of the isolated compounds 1-6 (chemical structures shown in Figure 2) 
were identified by analyzing the 1H and/or 13C NMR along with the Mass spectral 
data. These findings were then compared with previously published literature reports.  
The 1H and 13C NMR data for all the compounds are shown in Tables 1 (compounds 
1-2), Table 2 (compounds 3-4) and Table 3(compounds 5-6).  
Lyoniside (1): colorless needles; [M+Na]+ 575.1151 C27H36O12;  [α]D+43o. The 
1H and 13C NMR data were consistent with previous literature (Szakiel & Henry, 
2007).  
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Nudiposide (2): dark yellow needles; [M+ Na]+ 575.1151 C27H36O12; [α]D -
21.0o. The 1H and 13C NMR data were consistent with previous literature (Dada & 
Corbani, 1989).  See Table 1. 
Ssioriside (3): dark yellow amorphous powder: [M+ Na]+ 577.1291 C27H38O12. 
The 1H and 13C NMR data were consistent with previous literature (Kiyoshi, Yutaka, 
& Hiroko, 2005).  
Sinapic acid glucoside (4): light yellow color, C17H22O10. The NMR data for 
this compound are being reported here for the first time.   
Dulcisflavan (5): light brown color, C15H14O8. The 1H NMR data was 
consistent with previous literature (Deachathai, Mahabusarakam, Phongpaichit, & 
Taylor, 2005).  
Epigallocatechin (EGC) (6): light brown color, [M+ Na]+ 329.0633 C15H14O7. 
The 1H NMR data was consistent with previous literature (Yang, Chang, Chen, & 
Wang, 2003).  
2.5 Analytical HPLC 
All analyses were conducted with a Luna C18 column (250 x 4.6 mm i.d., 5 
µm; Phenomenex) with a flow rate at 0.8 mL/min and injection volume of 20 µL. A 
gradient solvent system consisting of solvent A (0.1% aqueous trifluroacetic acid) and 
solvent B (MeOH) was controlled throughout all analytical runs. 
2.6 Antioxidant Assay 
 The antioxidant potential of the blueberry crude extract were determined on the 
basis of their ability to scavenge the 1,1-diphenyl-2-picrylhydrazyl (DPPH) free 
radical as previously reported  (Li & Seeram, 2010). The positive controls that were 
 21 
 
used for this study ascorbic acid (vitamin C) and butylated hydroxytoluene (BHT). 
The assay was conducted on a 96-well format using serial dilutions of 50 µL aliquots 
of test compounds, vitamin C and BHT. After this, 100µL DPPH (80mg/mL) was 
added to each well.  Absorbance was determined after 30 min of reaction in the dark at 
515 nm with a micro-plate reader (SpectraMax M2, Molecular Devices Corp., 
operated by Softmax Pro v. 4.6 software, Sunnyvale, CA, USA). The scavenging 
capacity (SC) was calculated as %SC = [(A0 – A1) / A0] x 100, where A0 is the 
absorbance of the reagent blank and A1 is the absorbance of the test samples. All tests 
were performed in triplicate.  IC50 values denote the concentration of sample required 
to scavenge 50% DPPH free radicals. 
2.7 α-glucosidase Inhibitory Assay 
 The assay was conducted as previously reported. Briefly, a mixture of 50 µL of 
different concentrations of the compounds and 100 µL of 0.1 M phosphate buffer (pH 
6.9) containing yeast α-glucosidase solution (1.0 U/mL) was incubated in 96 well 
plates at 25oC for 10 min. After pre-incubation, 50 µL of 5 mM p-nitrophenyl- α-D-
glucopyranoside solution in 0.1 M phosphate buffer (pH 6.9) was added to each well 
at timed intervals. The reaction mixtures were incubated at 25oC for 5 min. 
Absorbance was recorded at 405 nm before and after incubation with a micro-plate 
reader (SpectraMax M2, Molecular Devices Corp., operated by SoftmaxPro v.4.6 
software, Sunnyvale, CA, USA) and compared to that of the control which had 50 µL 
acarbose instead of the test compounds. The α-glucosidase inhibitory activity was 
expressed as % inhibition and was calculated as follows: 
100  
 Abs
 Abs Abs
 inhibition %
control
samplecontrol
×





∆
∆−∆
=  
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2.8 Tyrosinase Inhibitory Assay 
 The enzymatic assay was conducted as previously reported. Briefly, L-DOPA 
was used as the substrate in this experiment. The activity was measured by 
spectrophotometrically.  A mixture of 1 mL of L-DOPA and 1.8 mL of 0.1 mL of PBS 
(pH= 6.8) was incubated in 96 well plates at 25oC for 10 min. After pre-incubation, 
0.1 mL of each compound and 0.1 mL of the tyrosinase solution were added to 
separate wells. The positive control was kojic acid. The samples were then compared 
to the control which is measured to have 100% inhibition. The reaction mixtures were 
incubated at 25oC for 5 min. Absorbance was recorded at 490 nm before and after 
incubation with a micro-plate reader (SpectraMax M2, Molecular Devices Corp., 
operated by SoftmaxPro v.4.6 software, Sunnyvale, CA, USA). The tyrosinase 
inhibitory activity was expressed as % inhibition and was calculated as follows: 
100  
 Abs
 Abs Abs
 inhibition %
control
samplecontrol
×





∆
∆−∆
=  
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Figure 5. The chemical structures of the isolated compounds: lyoniside (1); 
nudiposide (2); ssioriside (3); sinapic acid glycoside (4); dulcisflavan (5); and 
epigallocatechin (6)  
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Table 1. δH and δC (400MHz) NMR Spectra Data of lyoniside (1) and 
nudiposide (2) (CD3OD) (δ in ppm) 
  1 
  
2 
  
Position δH δC δH δC 
 
1 
 
139.3 
 
139.0 
2,6 6.43,6.42 s 106.9 6.42, s, 2H 107.0 
3,5 
 
149.0 
 
149.1 
4 
 
134.5 
 
134.0 
7 4.38, t 43.2 4.23, t, J= 7.2 43.5 
8 2.1, m 46.9 2.02, m 47.0 
9 3.83, 2H, m 71.0 3.83, 3.5, m 71.1 
1' 
 
126.5 
 
126.0 
2' 
 
147.7 
 
147.8 
3' 
 
139.1 
 
139.0 
4' 
 
148.8 
 
147.8 
5' 6.58, s 107.9 6.58, s 107.8 
6' 
 
130.2 
 
130.2 
7' 2.7, 2H, m 34.1 2.7, 2H, m 34.2 
8' 1.75, m 40.5 1.72, m 40.8 
9' 3.65, 3.58, m 66.1 3.8, 3.5, m 66.1 
OCH3 
 
60.1 
 
60.1 
3xOCH3 
 
56.6 
 
56.6 
1'' 4.23, d, J= 7.2 105.7 4.10, d, J= 7.2 105.7 
2'' 3.25, m 75.1 3.25, m 75.1 
3'' 3.35, m 78.2 3.35, m 78.1 
4'' 3.50, m 71 3.50, m 71.4 
5'' 3.5, 3.83, m 67.1 3.5, 3.80, m 67.2 
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Table 2. δH and δC (400MHz) NMR Spectra Data of ssioriside (3) and 
sinapic acid glycoside (4) (CD3OD) (δ in ppm) 
  3 
  
4 
position δH δC δH δC 
1 
 
133.1 
 
130.8 
2 6.35 or 6.33, 
s 
107.2 6.58, s, J= 16.5 105.8 
3 
 
149.0 
 
153.1 
4 
 
133.3 
 
144.7 
5 4.38, t 149.0 
 
153.1 
6 6.35 or 6.33 
s 
107.1 6.58, s, J= 16.5 105.8 
7 2.56, m 36.2 6.36, d, J= 16.5 108.1 
8 2.06, m 44.2 7.53, d, J= 16.5 117.0 
9 3.55, 3.86, m 70.96 
 
68.9 
10    
 
1' 
 
133.1 4.89, d, J= 7.5 Hz 103.4 
2' 6.35, s 107.1 3.17-3.4, m 77.3 
3' 
 
149.0 3.17-3.4, m 76.4 
4' 
 
133.3 3.17-3.4, m 74.3 
5' 
 
149.0 3.17-3.4, m 69.9 
6' 6.35, s 107.1 3.57 and 3.66, d 61.1 
7' 2.56, 2.62, m 36.4 
 
8' 1.94, m 41.47 
 
9' 3.98, 3.47, m 62.8 
 
OCH3 3.75, s 56.7 3.79, s 55.7 
OCH3 3.75, s 56.7 3.79, s 55.7 
OCH3 3.75, s 56.7 
 
OCH3 3.75, s 56.7 
 
1'' 4.19, d, J= 7.2 105.5  
2'' 3.2-3.8, m 75.2 
 
3'' 3.2-3.8, m 78.1 
 
4'' 3.2-3.8, m 71.4 
 
5'' 3.2-3.8, m 67.2 
6'' 
 
 
  
7'' 
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Table 3. δH (400MHz) NMR Spectra Data of dulcisflavan (5) 
and epigallocatechin (6) (CD3OD) (δ in ppm) 
  5 6 
Position δH δH 
1  
 
2 4.82, s 4.4, s 
3 4.18, br, s 3.4, br, s 
4 2.88, d, J=17.0, 5.0       
2.75 dd, J=17.0, 3.0 
2.8, d, 2.7, d 
5   
6  5.9 
7  
 
8  5.9 
9  
 
1'  
 
2' 6.97, d, J= 2.0 6.5, s 
3'  
 
4'  
 
5' 6.76, d, J=8.0 
 
6' 6.81, dd, J=8.0, 2.0 6.5,s 
   
 
 
3. Results and Discussion: 
3.1 Isolation and Structural Elucidation of Compounds 
 Six phenolic compounds (chemical structures shown in Figure 5) were isolated 
from the roots of the highbush blueberry plant using a variety of chromatographic 
techniques (see Figure 4). The compounds were identified by using NMR and Mass 
spectral data and then compared to previous literature. The 13C NMR data for 
compounds 1-2 and 3-4 are provided in Table 1 and 2, respectively. The 1H NMR data 
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for compounds; 1-2, 3-4, 5-6 are provided in Table 1, 2 and 3, respectively. For ease 
of discussion, the isolates are grouped into three phenolic sub-classes as follows. 
3.2 Lignans 
 The blueberry roots isolates included lignans and were identified as lyoniside 
(1), nudiposide (2), ssiorside (3). Lyoniside was obtained from the European blueberry 
known as the bilberry (Szakiel, Voutquenne-Nazabadioko, & Henry, 2011). However; 
this is the first report of compounds, 2 and 3 being isolated from the blueberry plant. 
3.3 Phenolic acid 
 One phenolic acid was isolated from the highbush blueberry roots and 
identified as sinapic acid glycoside (4). This is the first report of sinapic acid glycoside 
being isolated from the blueberry plant. 
3.4 Catechins 
 Two catechins were isolated from the highbush blueberry roots and were 
identified as dulcisflavan (5) and epigallocatechin (6). This is the first report of 
compound 5 from the genus Vaccinium. 
3.5 Antioxidant Activity 
 Blueberry fruits are a good source of antioxidants. Thus, a preliminary study 
was conducted to test the crude extract of the blueberry roots. It was observed that the 
roots had free-radical scavenging activity in vitro.  
3.6 α-glucosidase enzyme Inhibitory Activity 
 The number of people with diabetes is increasing by 4-5% each year and 
through its long-term effect it is the cause of the of the highest morbidity rate around 
the globe. Wan et al. showed that the flavonol glycosides and phenylpropanoid-
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substituted catechins isolated from the flowers of the highbush blueberry showed 
superior α-glucosidase inhibitory activity compared to the positive control, acarbose 
(Wan, Yuan, Cirello, & Seeram, 2012).  Moghe et al. showed that blueberry 
polyphenols suppressed adipocyte differentiation in the cell lines at three doses.  The 
higher doses had a stronger effect against mouse 3T3-F442A preadipocyte cell lines 
(Moghe, Juma, Imrhan, & Vijayagopal, 2012). With much effort focused on diabetes 
research and the positive results from the study of the blueberry flowers, it is 
worthwhile to investigate the pure compounds of the roots for their α-glucosidase 
inhibitory activity. Of the six compounds evaluated, ssioriside was a moderate 
inhibitor of α-glucosidase (IC50 = 650 µM). 
3.7 Tyrosinase enzyme Inhibitory Activities  
 Melanin’s main function in humans is to protect the skin from harmful effects 
of UV radiation from the sun.  Melanin is produced through a mechanism in which 
tyrosinase plays a major role.  Tyrosinase is a multifunctional enzyme which catalyzes 
the first two steps in the formation of melanin.  It is also responsible for enzymatic 
browning of fruit after harvesting during the handling and processing. Although, 
melanin is important in protecting the skin an accumulation of abnormal amounts of 
melanin can lead to cancer (Matsuura, Ukeda, & Sawamura, 2006). Therefore, it is 
important to look into potent tyrosinase inhibitors. Of the compounds tested the only 
compound to show inhibitory effects was epigallocatechin (IC50 = 2001 µM). 
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Table 4 
α-glucosidase & tyrosinase enzyme inhibitory activities of 
compounds 1-7. Antioxidant activity of crude root extract 
Compounds 
 
IC50 (µM)a 
 
  
  α-glucosidase tyrosinase Antioxidant   
lyoniside n.d. n.d. 
nudiposide n.d. n.d. 
ssioriside 650 n.d. 
sinapic acid 
glycoside n.d. n.d. 
dulcisflavan n.d. n.d. 
epigallocatechin n.d. 2001 
Crude root 
extract - - 42 (µg/mL) 
BHTb 
- 
- 
Vitamin Cb 
- 
- 
 
 
Kojic acidb 
- 
830 
-  
Acarboseb 170  - - 
n.d. = not 
detected       
a IC50 values  
b
 Positive 
control 
 
  
 
4. Conclusion: 
 In summary, six phenolics were isolated from highbush blueberry roots. This is 
the first report of nudiposide, ssioriside, sinapic acid glycoside, and dulcisflavan to be 
isolated from this genus. The structural elucidation of the phenolic compounds from a 
non-consumed plant part could help to further understand the potential health benefits 
of secondary metabolites of natural products. This supports the data suggesting that 
phenolic compounds are known to have potential nutraceutical applications. Non-
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consumed plant parts from food plants should be exploited as potential sources of 
bioactive compounds.   
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CONCLUSION 
In this phytochemical study, the focus was on Northern Highbush blueberry 
(Vaccinum corymbosum) constituents obtained from the roots. Previous studies 
reported that blueberry fruit contain phenolic compounds which are praised for having 
positive health benefits which led to further examination of the plants’ composition 
beyond the fruit.  
Blueberries are known not only to be packed with antioxidants but also to aid 
in inhibiting cell proliferation and adipogensis and to help promote urinary tract health 
and digestion (Moghe et al. 2012; Wan et al. 2012). Along with being naturally sweet, 
blueberries contain 14mg of vitamin C in one serving, which is 25% of one’s 
recommended daily requirement. They are also an excellent source of manganese, 
which plays an important role in bone development and conversion of proteins, 
carbohydrates and fats into energy. Blueberry producers convert the fruit into many 
consumable products including beverages, cakes, jams and dried fruits. Scientific 
studies have shown that the fruit of blueberries possess a range of pharmacological 
properties and are leaders in antioxidant activity (Su, 2012).  
The compounds isolated from the roots have been previously reported in other 
plant species and their plant parts.  All compounds besides sinapic acid glycoside have 
been tested and reported to have biological activity which may contribute to human 
health(Matsuda, Ishikado, Nishida, Ninomiya, Fujwara, Kobayashi, et al., 1998; 
Szakiel & Henry, 2007; Szakiel, Voutquenne-Nazabadioko, & Henry, 2011; Yang, 
Chang, Chen, & Wang, 2003). 
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 Nudiposide was isolated from the root barks of Ulmus davidiana var. japonica 
by Zeng et al. in 2011. Zeng et al. reported that nudiposide exhibited the most potent 
protective effect against sepsis in vivo. Sepsis is a clinical syndrome defined by the 
presence of both infection and systemic inflammatory response. It is often life-
threatening, especially in people with a weakened immune system or with chronic 
illness. Zeng et al. also reported that nudiposide decreased the plasma levels of TNF-
α, IL-10 and ALT activity (Zeng et al. 2011).  
 Matsuda et al. conducted a preliminary study of 50% aqueous methanolic 
extract from the bark of Betula platyphylla which showed potent inhibiting activity 
against liver injury induced by CCl4 (Matsuda, et al., 1998). They then isolated 
nudiposide and lyoniside and revealed that these compounds had a positive effect on 
lipid peroxidation. Due to their antioxidative activity, it is believed these compounds 
are responsible for the potent inhibitory effect upon liver injury (Matsuda, et al., 
1998).  
 Lyoniside was also isolated from the inner bark of Betula pendula by Smithe et 
al. in 1995 (Smite, Pan, & Lundgren, 1995).  The compound was then re-isolated from 
the rhizomes and stems of Vaccinium myrtillus in 2011 by Szakiel et al. Lyoniside 
showed significant radical scavenging properties in a 2,2-diphenyl-1-picrylhydrazyl 
(DPPH) assay.  The group also reported that lyoniside exerted strong antifungal 
activity (Szakiel, Voutquenne-Nazabadioko, & Henry, 2011).  
Ssioriside was isolated from the root bark of Ulmus davidiana that is able to 
inhibit cellular senescence in HDFs and human umbilical vein endothelial cells. 
Twenty-two compounds from the root bark of Ulmus davidiana were isolated and 
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screened for their inhibitory effects on adriamycin-induced cellular senescence by 
measuring senescence-associated β-galatosidase activity. Among those twenty-two 
compounds isolated, ssioriside had shown significant inhibitory effects on adriamycin-
induced cellular senescence in HDFs (Yang 2010). 
A plethora of data has been reported on epigallocatechin. This compound 
possesses two epimers. The most common is (-)-epigallocatechin, most commonly 
found in green tea. This plant is used as folk medicine for stomach disorders and 
diarrhea. Catechins are known for their health-promoting effects (Ruidavets, 
Teissedre, Ferrieres, Carando, Bougard, & Cabanis, 2000). These include the slowing 
of age-related cognitive decline, according to Kuriyama et al. in 2006, and protection 
against obesity (Kao, Hiipakka, & Liao, 2000; Kuriyama, Hozawa, Ohmori, Shimazu, 
Matsui, Ebihara, et al., 2006). At the cellular level, catechins induce anti-inflammatory 
(Tedeschi, Suzuki, & Menegazzi).  
Ruidavets et al. in 2000 reported which type of diet contributes most to plasma 
concentration of (+)-catechin by testing 180 subjects (Ruidavets, Teissedre, Ferrieres, 
Carando, Bougard, & Cabanis, 2000). A blood sample was collected after a fasting 
period, and (+)-catechin measurement in plasma was performed by HPLC method 
using fluorescence detection. Dietary consumption of the last evening meal was 
assessed by a dietary recall method. Taking fruit, vegetable and wine consumption 
into account, four types of diets were identified. After adjustment for confounding 
factors, concentration of (+)-catechin in plasma was three-fold higher in diet with fruit 
and vegetable but without wine (449.5 mg/l), and four-fold higher in diet with wine 
but without vegetable and fruit (598.5 mg/l) in comparison to diet without fruit, 
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vegetable and wine (131.6 mg/l). When the consumption of vegetable, fruit and wine 
was combined, the concentration was the highest (637.1 mg/l). Vegetable, fruit and 
wine were the major determinants of plasma (+)-catechin concentration. This study 
demonstrates that the highest plasma concentration of (+)catechin was observed in 
subjects consuming fruit, vegetable and wine, and its antioxidant and antiaggregant 
activity may be able to explain the relative protection against coronary heart disease 
(Ruidavets, Teissedre, Ferrieres, Carando, Bougard, & Cabanis, 2000). 
Catechins have also been associated with a lower prevalence of cognitive 
impairment in humans. Kuriyama et al. examined the association between green tea 
consumption and cognitive function in humans. They analyzed data from a 
community-based Comprehensive Geriatric Assessment conducted in 2002. The 
subjects were 1,003 Japanese subjects aged less than 70 years old. They completed a 
self-administered questionnaire that included questions about the frequency of green 
tea consumption and evaluated cognitive function by using the Mini-Mental State 
Examination. Higher consumption of green tea was associated with a lower incidence 
of cognitive impairment (Kuriyama, et al., 2006). 
Dulcisflavan was previously isolated from Garcinia dulcis Kurz (Deachathai et 
al. 2005) and Spatholobus suberectus (Ren-Neng et al. 2012). It is a medicinal plant 
used in Oriental folk medicine. In Thailand, its bark has been used as an anti-
inflammatory agent; and  in other traditional medicines, the fruit juice has been used 
as an expectorant (Deachathai, Mahabusarakam, Phongpaichit, & Taylor, 2005). 
Deachathai et al. reported on the antibacterial and radical scavenging abilities of this 
compound which had promising results. Dulcisflavan gave a reduction greater than 
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that produced by the positive control which was10µM BHT (Deachathai, 
Mahabusarakam, Phongpaichit, & Taylor, 2005). 
Part I reviews the background of natural products while part II is the review of 
isolation and elucidation of phytochemicals extracted from the roots of the Northern 
Highbush blueberry which yielded six pure compounds: ssisoriside, lyoniside, 
nudiposide, sinapic acid glucoside, epigallocatechin and dulcisflavan. These 
compounds were elucidated using spectroscopic techniques including 1D- and 2D-
NMR and mass spectrometry. The NMR data was confirmed by comparing it to 
previously published literature. The isolated compounds were tested for α-glucosidase 
and tyrosinase inhibitory activity.  
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